
<oai_dc:dc xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/">
  <dc:description xml:lang="eng">The skin is the largest human organ covering the entire
body. It is composed of layers of cells that act like a barrier
and keep substances from permeating and entering the
systemic circulation. The release of the active substance
from vehicle is the first important step in achieving an
adequate effect of the drug. In case of topical application,
it should permeate through the skin in order to achieve a
local effect, avoiding systemic absorption (Hadgraft et al.,
2005). Franz diffusion cells are a widely used methodology
to evaluate in vitro drug permeation (Bielfeldt et al., 2022).
Recently, spironolactone (SP) was introduced as off-label
topical acne therapy, in order to reduce side effects when
administered orally (Salama et al., 2020). Alkyl
polyglucoside (APG)-based emulsions with 5% of SP
showed acceptable skin irritation profiles, which indicate
that these emulsions could be used as prospective carriers
for off-label topical SP (Ilic et al., 2021). This work’s main
objective was to examine the SP permeation through skin
from different APG-based topical emulsions with or
without glycolic acid (GA) as excipient, using Franz
diffusion cells.</dc:description>
  <dc:title xml:lang="eng">In vitro spironolactone permeation study: role of different alkyl polyglucoside emulsifiers and glycolic acid</dc:title>
  <dc:type>info:eu-repo/semantics/conferenceProceedings</dc:type>
  <dc:rights>All rights reserved</dc:rights>
  <dc:source>Македонски Фармацевтски билтенMacedonian Pharmaceutical Bulletin</dc:source>
  <dc:source>vol. 69</dc:source>
  <dc:source>str. 135-136</dc:source>
  <dc:date>2023</dc:date>
  <dc:creator>Ilić, Dušan</dc:creator>
  <dc:creator>Cvetković, Maja</dc:creator>
  <dc:creator id="https://orcid.org/0000-0002-7722-6169">Žugić, Ana</dc:creator>
  <dc:creator>Sunarić, Slavica</dc:creator>
  <dc:creator>Tasić-Kostov, Marija</dc:creator>
  <dc:format>application/pdf</dc:format>
  <dc:format>2055028 bytes</dc:format>
  <dc:identifier>https://unilib.phaidrabg.rs/o:5503</dc:identifier>
  <dc:identifier>doi:10.33320/maced.pharm.bull.2023.69.03.066</dc:identifier>
  <dc:identifier>ISSN: 1857 - 8969</dc:identifier>
  <dc:language>eng</dc:language>
</oai_dc:dc>
